News2024-10-10T21:11:12-07:00

News

Alumnus Spotlight on Meet Vora

December 3rd, 2024|Alumni News|

GraphWear has raised $28 million in funding to date, enabling critical advancements in its technology and expanding its reach through clinical trials and strategic collaborations. As an MBC BioLabs alumnus, Meet’s story exemplifies the entrepreneurial spirit and dedication fostered by the MBC BioLabs community, reflecting how innovation can thrive from modest beginnings.

Dren Bio Announces Strategic Collaboration with Novartis

July 31st, 2024|Featured, Alumni News|

We are thrilled to share the news of a strategic collaboration between Dren Bio, one of our distinguished alumni, and Novartis to develop bispecific antibody therapies targeting cancer. This partnership, which builds on Dren Bio’s targeted myeloid engager and phagocytosis platform, includes an upfront payment of $150 million from Novartis, with $25 million as an equity investment.

We Are Proud to Announce our Partnership with HitGen to Accelerate Biotechnology Discovery!

April 1st, 2024|Featured, MBC Biolabs News|

LabCentral, a launchpad for high-potential life science and biotech start-ups, BioLabs, an international membership-based network of shared lab and office facilities, and MBC BioLabs, premier providers of co-working laboratory space, today announced a partnership with HitGen, a global leader in the design, synthesis, and screening of DNA-encoded chemical libraries (DELs).

Go to Top